Abstract:Few studies elicit values for SWD. The lead time approach is a potential alternative to the Torrance and MVH protocols. Key words: QALY; states worse than dead; health state valuation; preference elicitation.
“…LT-TTO may have other protocol-specific learning effects. The same applies to other alternative TTO variants, for instance, when using lag time [18].…”
TTO values become more extreme with increasing experience. Because of the randomized valuation order, these effects do not bias specific health states; however, they reduce the overall validity and reliability of TTO values.
“…LT-TTO may have other protocol-specific learning effects. The same applies to other alternative TTO variants, for instance, when using lag time [18].…”
TTO values become more extreme with increasing experience. Because of the randomized valuation order, these effects do not bias specific health states; however, they reduce the overall validity and reliability of TTO values.
“…Thus, the boundaries of valuation are -1 and 1. The reasons for doing so have been widely discussed elsewhere, including a recent review article [23].…”
Section: General Population Valuation Taskmentioning
“…Their survey describes each "life" according to a different set of EuroQol ratings (expressed in words), and the duration in that health state is described as one of 10, 7, 4, or 1 year, followed by death. They use a specification for the systematic 11 In this literature, there has been considerable attention to the possibility of states worse than dead (see Tilling et al 2010). portion of utility that forces fitted utility to be proportional to the time spent in the given state.…”
Section: Measuring the Quantity Of Morbidity In Illness Attribute Spacementioning
For benefit-cost analysis of policies with respect to environmental and natural resources, economic researchers often require monetized values of households' willingness to pay for reductions in risks to human life and health. I briefly recap some of the main issues in the related task of valuing reductions in the risk of death. These issues also account for our considerably smaller literature on valuing reductions in morbidity risks. An important distinction is the issue of valuation in the space of illnesses versus valuation in the space of illness attributes. I compare the requirements for environmental benefit-cost analysis with the limitations of the standard approaches taken in costeffectiveness analysis in health economics, and I highlight some areas that are ripe for further research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.